Icaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular Carcinoma

Clinical trial NCT06896396 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06896396
Sponsor: Zhiyong Huang
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Unresectable Hepatocellular Carcinoma

Start date: 2025-04-01
Primary completion: 2027-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.